Increased expression of epimorphin in a peritoneal fibrosis mouse model

1. Krediet, RT . The peritoneal membrane in chronic peritoneal dialysis. Kidney Int 1999; 55: 341–356.
Google Scholar | Crossref | Medline2. Jain, AK, Blake, P, Cordy, P, et al. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23: 533–544.
Google Scholar | Crossref | Medline3. Coles, GA, Topley, N. Long-term peritoneal membrane changes. Adv Ren Replace Ther 2000; 7: 289–301.
Google Scholar | Crossref | Medline4. Williams, JD, Craig, KJ, Topley, N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13: 470–479.
Google Scholar | Crossref | Medline5. Yanez-Mo, M, Lara-Pezzi, E, Selgas, R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403–413.
Google Scholar | Crossref | Medline6. Jagirdar, RM, Bozikas, A, Zarogiannis, SG, et al. Encapsulating peritoneal sclerosis: pathophysiology and current treatment options. Int J Mol Sci 2019; 20: 5765.
Google Scholar | Crossref7. Loureiro, J, Aguilera, A, Selgas, R, et al. Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 2011; 22: 1682–1695.
Google Scholar | Crossref | Medline8. Sakai, N, Nakamura, M, Lipson, KE, et al. Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis. Sci Rep 2017; 7: 5392.
Google Scholar | Crossref | Medline9. Liu, Y . Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 2011; 7: 684–696.
Google Scholar | Crossref | Medline10. Witowski, J, Kawka, E, Rudolf, A, et al. New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis. Biomed Res Int 2015; 2015: 134708.
Google Scholar | Crossref | Medline11. Chen, YT, Chang, YT, Pan, SY, et al. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. J Am Soc Nephrol 2014; 25: 2847–2858.
Google Scholar | Crossref | Medline12. Wynn, TA . Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524–529.
Google Scholar | Crossref | Medline13. Tomino, Y . Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol 2011; 16: 109–114.
Google Scholar | Crossref | Medline14. Zhou, Q, Bajo, MA, Del Peso, G, et al. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 2016; 90: 515–524.
Google Scholar | Crossref | Medline15. Liu, N, Tolbert, E, Pang, M, et al. Suramin inhibits renal fibrosis in chronic kidney disease. J Am Soc Nephrol 2011; 22: 1064–1075.
Google Scholar | Crossref | Medline16. Bonner, JC . Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 2004; 15: 255–273.
Google Scholar | Crossref | Medline17. Liu, F, Zhuang, S. Role of receptor tyrosine kinase signaling in renal fibrosis. Int J Mol Sci 2016; 17: 972.
Google Scholar | Crossref18. Heldin, CH, Westermark, B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999; 79: 1283–1316.
Google Scholar | Crossref | Medline19. Trojanowska, M . Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 2008; 47(Suppl 5): v2–v4.
Google Scholar | Crossref | Medline20. Andrae, J, Gallini, R, Betsholtz, C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008; 22: 1276–1312.
Google Scholar | Crossref | Medline21. Li, L, Shen, N, Wang, N, et al. Inhibiting core fucosylation attenuates glucose-induced peritoneal fibrosis in rats. Kidney Int 2018; 93: 1384–1396.
Google Scholar | Crossref | Medline22. Hirai, Y, Takebe, K, Takashina, M, et al. Epimorphin: a mesenchymal protein essential for epithelial morphogenesis. Cell 1992; 69: 471–481.
Google Scholar | Crossref | Medline23. Hirai, Y, Lochter, A, Galosy, S, et al. Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 1998; 140: 159–169.
Google Scholar | Crossref | Medline24. Miura, K, Nagai, H, Ueno, Y, et al. Epimorphin is involved in differentiation of rat hepatic stem-like cells through cell-cell contact. Biochem Biophys Res Commun 2003; 311: 415–423.
Google Scholar | Crossref | Medline25. Yamada, M, Oda, T, Higashi, K, et al. Involvement of epimorphin in the repair of experimental renal fibrosis in mice. Lab Invest 2010; 90: 867–880.
Google Scholar | Crossref | Medline26. Terasaki, Y . Epimorphin in bleomycin-induced pulmonary fibrosis in mice. Chest 2001; 120: 30S–32S.
Google Scholar | Crossref | Medline27. Terasaki, Y, Fukuda, Y, Suga, M, et al. Epimorphin expression in interstitial pneumonia. Respir Res 2005; 6: 6.
Google Scholar | Crossref | Medline28. Segawa, D, Miura, K, Goto, T, et al. Distribution and isoforms of epimorphin in carbon tetrachloride-induced acute liver injury in mice. J Gastroenterol Hepatol 2005; 20: 1769–1780.
Google Scholar | Crossref | Medline29. Pritchett, J, Athwal, VS, Harvey, E, et al. Epimorphin alters the inhibitory effects of SOX9 on Mmp13 in activated hepatic stellate cells. PLoS One 2014; 9: e100091.
Google Scholar | Crossref | Medline30. Kushiyama, T, Oda, T, Yamada, M, et al. Effects of liposome-encapsulated clodronate on chlorhexidine gluconate-induced peritoneal fibrosis in rats. Nephrol Dial Transplant 2011; 26: 3143–3154.
Google Scholar | Crossref | Medline31. Masola, V, Granata, S, Bellin, G, et al. Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. Nephrol Dial Transplant 2017; 32: 1145–1154.
Google Scholar | Medline32. Yokoi, H, Kasahara, M, Mori, K, et al. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice. Perit Dial Int 2013; 33: 143–154.
Google Scholar | SAGE Journals33. Baum, J, Duffy, HS. Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol 2011; 57: 376–379.
Google Scholar | Crossref | Medline34. Borkham-Kamphorst, E, Weiskirchen, R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev 2016; 28: 53–61.
Google Scholar | Crossref | Medline35. Chen, YT, Chang, FC, Wu, CF, et al. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011; 80: 1170–1181.
Google Scholar | Crossref | Medline36. Fan, H, Ma, L, Fan, B, et al. Role of PDGFR-β/PI3K/AKT signaling pathway in PDGF-BB induced myocardial fibrosis in rats. Am J Transl Res 2014; 6: 714–723.
Google Scholar | Medline37. Hung, C, Linn, G, Chow, YH, et al. Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013; 188: 820–830.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif